Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA ALEMBIC PHARMA LACTOSE INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 33.2 32.1 103.5% View Chart
P/BV x 4.3 4.4 98.3% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 LACTOSE INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
ALEMBIC PHARMA
Mar-23
LACTOSE INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs96792 12.2%   
Low Rs39463 8.5%   
Sales per share (Unadj.) Rs52.3287.6 18.2%  
Earnings per share (Unadj.) Rs1.017.4 5.5%  
Cash flow per share (Unadj.) Rs4.731.4 14.9%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Avg Dividend yield %01.3 0.0%  
Book value per share (Unadj.) Rs32.2222.3 14.5%  
Shares outstanding (eoy) m12.59196.56 6.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.2 59.4%   
Avg P/E ratio x70.636.1 195.7%  
P/CF ratio (eoy) x14.520.0 72.5%  
Price / Book Value ratio x2.12.8 74.5%  
Dividend payout %046.0 0.0%   
Avg Mkt Cap Rs m854123,402 0.7%   
No. of employees `000NANA-   
Total wages/salary Rs m12211,691 1.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m65856,526 1.2%  
Other income Rs m730 24.0%   
Total revenues Rs m66556,557 1.2%   
Gross profit Rs m1156,772 1.7%  
Depreciation Rs m472,754 1.7%   
Interest Rs m60502 12.0%   
Profit before tax Rs m153,546 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3126 2.0%   
Profit after tax Rs m123,420 0.4%  
Gross profit margin %17.412.0 145.3%  
Effective tax rate %17.53.6 491.0%   
Net profit margin %1.86.1 30.4%  
BALANCE SHEET DATA
Current assets Rs m37529,139 1.3%   
Current liabilities Rs m26616,408 1.6%   
Net working cap to sales %16.622.5 73.8%  
Current ratio x1.41.8 79.5%  
Inventory Days Days4610 470.1%  
Debtors Days Days6937 10,256.3%  
Net fixed assets Rs m64331,498 2.0%   
Share capital Rs m126393 32.0%   
"Free" reserves Rs m28043,312 0.6%   
Net worth Rs m40643,705 0.9%   
Long term debt Rs m3300-   
Total assets Rs m1,01860,637 1.7%  
Interest coverage x1.28.1 15.4%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.60.9 69.3%   
Return on assets %7.16.5 110.1%  
Return on equity %3.07.8 38.1%  
Return on capital %10.29.3 110.0%  
Exports to sales %046.4 0.0%   
Imports to sales %31.312.1 258.7%   
Exports (fob) Rs mNA26,210 0.0%   
Imports (cif) Rs m2066,846 3.0%   
Fx inflow Rs m10426,210 0.4%   
Fx outflow Rs m2096,846 3.0%   
Net fx Rs m-10519,364 -0.5%   
CASH FLOW
From Operations Rs m817,240 1.1%  
From Investments Rs m-10-4,476 0.2%  
From Financial Activity Rs m-84-2,620 3.2%  
Net Cashflow Rs m-13144 -9.3%  

Share Holding

Indian Promoters % 53.7 69.1 77.7%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 0.6 19.0 3.3%  
FIIs % 0.0 4.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.3 30.4 152.5%  
Shareholders   16,088 85,212 18.9%  
Pledged promoter(s) holding % 26.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LACTOSE INDIA vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LACTOSE INDIA vs ALEMBIC PHARMA Share Price Performance

Period LACTOSE INDIA ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day -1.83% -0.45% 1.18%
1-Month -2.41% -4.58% -0.75%
1-Year 226.47% 104.81% 61.82%
3-Year CAGR 73.96% 0.79% 18.16%
5-Year CAGR 33.74% 13.50% 19.79%

* Compound Annual Growth Rate

Here are more details on the LACTOSE INDIA share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of LACTOSE INDIA hold a 53.7% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LACTOSE INDIA and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, LACTOSE INDIA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of LACTOSE INDIA, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.